Pharmacokinetics in Animals and Humans of a First-in-Class Peptide Deformylase Inhibitor
BB-83698, a potent and selective inhibitor of peptide deformylase, was the first compound of this novel antibacterial class to progress to clinical trials. Single- and/or multiple-dose studies with doses ranging from 10 to 50 mg of BB-83698/kg of body weight were done with mice, rats, and dogs. Intr...
Kaydedildi:
| Yayımlandı: | Antimicrob Agents Chemother |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
2004
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC529202/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15561864/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.12.4835-4842.2004 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
